[
    [
        {
            "time": "",
            "orginal_text": "医药生物行业周报:三季报披露期,坚守业绩主线",
            "features": {
                "keywords": [
                    "医药生物",
                    "三季报",
                    "业绩",
                    "披露"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "医药生物行业周报:三季报披露期,坚守业绩主线",
            "scores": {
                "News_content": "医药生物行业周报:三季报披露期,坚守业绩主线",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "泰格医药三季报跟踪:Q3增速放缓,无碍长期发展前景",
            "features": {
                "keywords": [
                    "泰格医药",
                    "三季报",
                    "Q3",
                    "增速",
                    "长期发展"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "泰格医药三季报跟踪:Q3增速放缓,无碍长期发展前景",
            "scores": {
                "News_content": "泰格医药三季报跟踪:Q3增速放缓,无碍长期发展前景",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物行业周报:行业估值位于历史底部,可逐步配置优质个股",
            "features": {
                "keywords": [
                    "医药生物",
                    "估值",
                    "历史底部",
                    "优质个股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "医药生物行业周报:行业估值位于历史底部,可逐步配置优质个股",
            "scores": {
                "News_content": "医药生物行业周报:行业估值位于历史底部,可逐步配置优质个股",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "大额回购+业绩预喜，这些超跌股已获北上资金“举牌” 盈利能力下降",
            "features": {
                "keywords": [
                    "大额回购",
                    "业绩预喜",
                    "超跌股",
                    "北上资金",
                    "盈利能力下降"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "大额回购+业绩预喜，这些超跌股已获北上资金“举牌” 盈利能力下降",
            "scores": {
                "News_content": "大额回购+业绩预喜，这些超跌股已获北上资金“举牌” 盈利能力下降",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "A股2018年震荡走低，三板块逆势逞强走出独立行情",
            "features": {
                "keywords": [
                    "A股",
                    "2018年",
                    "震荡走低",
                    "三板块",
                    "独立行情"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "A股2018年震荡走低，三板块逆势逞强走出独立行情",
            "scores": {
                "News_content": "A股2018年震荡走低，三板块逆势逞强走出独立行情",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]